In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Arena awarded Phase I SBIR grant to develop antipsychotics
Inhibitex awarded SBIR grant for vaccine development
SBIR grant awarded to Atlantic Pharmaceuticals' subsidiary Gemini Technologies
Boston Biomedica awarded SBIR Grant
Bolder BioTechnology awarded SBIR grant
TransMolecular awarded Phase II SBIR grant
Aurora Biosciences announces collaboration with NCI for genome closure effort